These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9364192)
21. Metabolism of prednisolone 21-acetate in hairless mouse skin. Hikima T; Ohno Y; Maibach HI Skin Pharmacol Appl Skin Physiol; 2001; 14(4):203-9. PubMed ID: 11464102 [TBL] [Abstract][Full Text] [Related]
22. An in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol. Shameem M; Imai T; Otagiri M J Pharm Pharmacol; 1993 Apr; 45(4):246-52. PubMed ID: 8098362 [TBL] [Abstract][Full Text] [Related]
23. Enantioselectivity suggests a cytosolic origin for a commercial pig liver esterase preparation. Yang SK; Chen SJ; Huang JD Chirality; 1995; 7(1):40-3. PubMed ID: 7702997 [TBL] [Abstract][Full Text] [Related]
24. Esterase phenotyping in human liver in vitro: specificity of carboxylesterase inhibitors. Umehara K; Zollinger M; Kigondu E; Witschi M; Juif C; Huth F; Schiller H; Chibale K; Camenisch G Xenobiotica; 2016 Oct; 46(10):862-7. PubMed ID: 26887925 [TBL] [Abstract][Full Text] [Related]
25. Stereoselectivity and interaction between the glucuronidation of S-(-)- and R-(+)-propranolol in rat hepatic microsomes pretreated with different inducers. Luan LJ; Shao Q; Zeng S Pharmazie; 2005 Mar; 60(3):221-4. PubMed ID: 15801678 [TBL] [Abstract][Full Text] [Related]
26. Enantioselectivity of microsomal and cytosolic esterases in rat intestinal mucosa. Yang SK; Hsieh YY; Chang WC; Huang JD Drug Metab Dispos; 1992; 20(5):719-25. PubMed ID: 1358577 [TBL] [Abstract][Full Text] [Related]
27. Inter-individual variability in esterases in human liver. Jewell C; Bennett P; Mutch E; Ackermann C; Williams FM Biochem Pharmacol; 2007 Sep; 74(6):932-9. PubMed ID: 17651701 [TBL] [Abstract][Full Text] [Related]
28. Enzymic hydrolysis of nicotinate esters: comparison between plasma and liver catalysis. Durrer A; Wernly-Chung GN; Boss G; Testa B Xenobiotica; 1992 Mar; 22(3):273-82. PubMed ID: 1496819 [TBL] [Abstract][Full Text] [Related]
29. Species dependent esterase activities for hydrolysis of an anti-HIV prodrug glycovir and bioavailability of active SC-48334. Cook CS; Karabatsos PJ; Schoenhard GL; Karim A Pharm Res; 1995 Aug; 12(8):1158-64. PubMed ID: 7494828 [TBL] [Abstract][Full Text] [Related]
30. Enantioselective hydrolysis of lorazepam 3-acetate by esterases in human and rat liver microsomes and rat brain S9 fraction. Liu K; Guengerich FP; Yang SK Drug Metab Dispos; 1991; 19(3):609-13. PubMed ID: 1680626 [TBL] [Abstract][Full Text] [Related]
31. The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue. Mutch E; Nave R; McCracken N; Zech K; Williams FM Biochem Pharmacol; 2007 May; 73(10):1657-64. PubMed ID: 17331475 [TBL] [Abstract][Full Text] [Related]
32. Enantioselective oral bioavailability of 0-isovaleryl propranolol as a potential prodrug of propranolol. Shameem M; Imai T; Otagiri M J Pharmacobiodyn; 1992 Sep; 15(9):535-40. PubMed ID: 1287187 [TBL] [Abstract][Full Text] [Related]
33. Effects of sodium fluoride and cobalt chloride on the enantioselectivity of microsomal and cytosolic esterases in rat intestinal mucosa. Yang SK; Chang WC; Huang JD Biochem Pharmacol; 1993 Oct; 46(8):1511-4. PubMed ID: 8240404 [TBL] [Abstract][Full Text] [Related]
34. Esterase inhibition attribute of grapefruit juice leading to a new drug interaction. Li P; Callery PS; Gan LS; Balani SK Drug Metab Dispos; 2007 Jul; 35(7):1023-31. PubMed ID: 17392396 [TBL] [Abstract][Full Text] [Related]
35. Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen. Huttunen KM Bioorg Chem; 2018 Dec; 81():494-503. PubMed ID: 30243240 [TBL] [Abstract][Full Text] [Related]
36. Use of enzyme inhibitors to evaluate the conversion pathways of ester and amide prodrugs: a case study example with the prodrug ceftobiprole medocaril. Eichenbaum G; Skibbe J; Parkinson A; Johnson MD; Baumgardner D; Ogilvie B; Usuki E; Tonelli F; Holsapple J; Schmitt-Hoffmann A J Pharm Sci; 2012 Mar; 101(3):1242-52. PubMed ID: 22095741 [TBL] [Abstract][Full Text] [Related]
37. Comparison of percutaneous absorption and metabolism of di-n-butylphthalate in various species. Beydon D; Payan JP; Grandclaude MC Toxicol In Vitro; 2010 Feb; 24(1):71-8. PubMed ID: 19735722 [TBL] [Abstract][Full Text] [Related]
38. Acyloxymethyl acidic drug derivatives: in vitro hydrolytic reactivity. Redden PR; Melanson RL; Douglas JA; Dick AJ Int J Pharm; 1999 Apr; 180(2):151-60. PubMed ID: 10370185 [TBL] [Abstract][Full Text] [Related]
39. Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Anand SS; Bruckner JV; Haines WT; Muralidhara S; Fisher JW; Padilla S Toxicol Appl Pharmacol; 2006 Apr; 212(2):156-66. PubMed ID: 16169030 [TBL] [Abstract][Full Text] [Related]
40. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Quon CY; Mai K; Patil G; Stampfli HF Drug Metab Dispos; 1988; 16(3):425-8. PubMed ID: 2900735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]